UPDATED Aug 12, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €6.36 | -6.5% | -15.4% | €178.1m | €13.00 | PS18.2x | E60.0% | n/a | ||
ARGX | €552.40 | -7.8% | 13.7% | €33.8b | €701.74 | PE30.8x | E25.3% | n/a | ||
UCB | €187.05 | 0.1% | 21.7% | €35.5b | €219.56 | PE26.7x | E16.9% | 0.7% | ||
ALEMS | €4.62 | 0.5% | -37.5% | €19.6m | n/a | PE35.8x | n/a | n/a | ||
CYAD | €0.38 | 1.6% | 62.8% | €15.8m | n/a | PS84.9x | n/a | n/a | ||
OXUR | €0.03 | -1.3% | -97.0% | €1.5m | n/a | PE12.6x | n/a | n/a | ||
BIOS | €0.0023 | -8.0% | -75.5% | €1.5m | n/a | PE-0.2x | n/a | n/a | ||
TUB | €151.80 | -0.3% | 32.0% | €6.8b | €186.25 | PE72.9x | n/a | 0.7% |